Trial reportScientific reports2025
The effects of mediterranean and Persian diet on sexual function and semen parameters quality among infertile men: a randomized controlled trial.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The 24/7 lifestyle and male hormonal health: how sleep deprivation and ultra-processed foods impact testosterone and reproduction.Reviews in endocrine & metabolic disorders · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
There is no consensus on which diet best for improving male reproductive health and published studies on the effect of diet on sexual function and semen quality are limited. The aim of this study was to investigate the effect of intervention based diet, namely Persian Medicine Diet (PMD) and Mediterranean Diet (MD), on sexual function and semen quality parameters. In this single blind, randomized controlled clinical trial, 159 male patients with oligoasthenospermia aged between 18 and 45 years were enrolled and divided into three groups of 53 people each. The patients were randomly assigned to either PMD or MD intervention and control groups for two months between July 2022 and February 2023 in Shiraz, Iran. To evaluate the outcomes, we used the International Index of Erectile Function (IIEF-15) questionnaires that included five subscales and semen quality parameters. The mean age of the participants was 30.87 ± 6.55. Our analysis showed that total score of IIEF was higher in the PMD intervention (P ≤ 0.001). In addition, the PMD intervention showed a higher average difference in erectile function and intercourse satisfaction subscales, respectively (P ≤ 0.001, P ≤ 0.003). However, MD intervention showed a higher average difference in orgasm function subscale (P = 0.053). Additionally, in semen analysis, the study showed that MD intervention improved statistically. Also, semen count, sperm motility, and morphology difference improved significantly (all P ≤ 0.001). To improve infertility, PMD and MD interventions could positively impact male sexual function and semen quality parameters in infertile mess. Further studies with larger sample sizes and longer durations are needed for conclusive results.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.